Antisense strategies in dopamine receptor pharmacology (Q38350087)

2 September 2017

1 reference

title

Antisense strategies in dopamine receptor pharmacology (English)

1 reference

2 September 2017

1 reference

Weiss B

1

1 reference

2 September 2017

Zhang SP

series ordinal

2

1 reference

2 September 2017

Zhou LW

series ordinal

3

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

2 September 2017

1 reference

2 September 2017

60

1 reference

2 September 2017

7

1 reference

2 September 2017

433-455

1 reference

Adenyl cyclase activity in rat pineal gland: effects of chronic denervation and norepinephrine.

2 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Increased response to catecholamines of the cyclic AMP system of rat pineal gland induced by decreased sympathetic activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Selective down-regulation of D1 dopamine mediated rotational behavior in supersensitive mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

The current status of the dopamine hypothesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Muscarinic and dopaminergic receptor subtypes on striatal cholinergic interneurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Dopaminergic modulation of glutamate release in striatum as measured by microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

D2 dopamine receptor messenger RNA is altered to a greater extent by blockade of glutamate receptors than by blockade of dopamine receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Dopamine receptor blockade increases dopamine D2 receptor and glutamic acid decarboxylase mRNAs in mouse substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Dopaminergic and glutamatergic blocking drugs differentially regulate glutamic acid decarboxylase mRNA in mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Proenkephalin mRNA levels in rat striatum are increased and decreased, respectively, by selective D2 and D1 dopamine receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Regulation by dopaminergic neurotransmission of dopamine D2 mRNA and receptor levels in the striatum and nucleus accumbens of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Effect of raclopride on dopamine D2 receptor mRNA expression in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Up-regulation of dopamine D2 receptor mRNA in rat striatum by chronic neuroleptic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Multiple receptors for dopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Molecular biology of the dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Recent advances in the molecular biology of dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

The Mouse Dopamine D2AReceptor Gene: Sequence Homology with the Rat and Human Genes and Expression of Alternative Transcripts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Molecular biology of dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Cloning and expression of a rat D2 dopamine receptor cDNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Multiple D2 dopamine receptors produced by alternative RNA splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Shorter variants of the D3 dopamine receptor produced through various patterns of alternative splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Dopamine D3 receptor: basic and clinical aspects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Neuronal localization and modulation of the D2 dopamine receptor mRNA in brain of normal mice and mice lesioned with 6-hydroxydopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor autoradiographic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Differential visualization of dopamine D2 and D3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Ontogenetic expression of D2 dopamine receptor mRNA in rat corpus striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Developmental and age-related changes in the D2 dopamine receptor mRNA subtypes in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Decreased striatal D2 dopamine receptor mRNA synthesis during aging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Changes in dopamine D1, D2 and D3 receptor mRNA levels in rat brain following antipsychotic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Effect of haloperidol on expression of dopamine D2 receptor mRNAs in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Antisense oligonucleotides as antiviral agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Biphasic effect of D-2 agonist quinpirole on locomotion and movements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

SCH 23390—The first selective dopamine D-1 antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Irreversible blockade of D2 dopamine receptors by fluphenazine-N-mustard increases glutamic acid decarboxylase mRNA in rat striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

MK-801-induced stereotypy and its antagonism by neuroleptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Effects of the putative D-1 antagonist SCH 23390 on stereotyped behaviour induced by the D-2 agonist RU24213.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Therapeutic Applications of Oligonucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Effects of intrahypothalamic administration of antisense DNA for progesterone receptor mRNA on reproductive behavior and progesterone receptor immunoreactivity in female rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Inhibition of axonal growth by SNAP-25 antisense oligonucleotides in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Intracerebroventricular administration of AT1 receptor antisense oligonucleotides inhibits the behavioral actions of angiotensin II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Ventral tegmental area (VTA) injections of tyrosine hydroxylase phosphorothioate antisense oligonucleotide suppress operant behavior in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Antisense strategy unravels a dopamine receptor distinct from the D2 subtype, uncoupled with adenylyl cyclase, inhibiting prolactin release from rat pituitary cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Antisense oligodeoxynucleotide inhibits D2 dopamine receptor-mediated behavior and D2 messenger RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Protection of oligonucleotide primers against degradation by DNA polymerase I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Oligodeoxynucleoside phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Antisense genes in plants: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

The inhibition of neurite outgrowth in PC12 cells by tubulin antisense oligodeoxyribonucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Techniques for using antisense oligodeoxyribonucleotides to study gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Antisense oligodeoxyribonucleotides: stability and distribution after intracerebral injection into rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Effects of sequence of thioated oligonucleotides on cultured human mammary epithelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

The effects of selective dopamine receptor agonists and antagonists on body temperature in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Dopamine D3 receptor antisense influences dopamine synthesis in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Dopamine receptor changes following destruction of the nigrostriatal pathway: Lack of a relationship to rotational behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Cholinergic lesions of mouse striatum induced by AF64A alter D2 dopaminergic behavior and reduce D2 dopamine receptors and D2 dopamine receptor mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

A quantitative estimate of the role of striatal D-2 receptor proliferation in dopaminergic behavioral supersensitivity: the contribution of mesolimbic dopamine to the magnitude of 6-OHDA lesion-induced agonist sensitivity in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Expression of rat striatal D1 and D2 dopamine receptor mRNAs: ontogenetic and pharmacological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Lesions of mouse striatum induced by 6-hydroxydopamine differentially alter the density, rate of synthesis, and level of gene expression of D1 and D2 dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Differential effects of fluphenazine-N-mustard, on calmodulin activity and on D1 and D2 dopaminergic responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Comparison of the effects of fluphenazine-N-mustard on dopamine binding sites and on behavior induced by apomorphine in supersensitive mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Functional recovery of D1 dopamine receptor-mediated stimulation of rat striatal adenylate cyclase activity following irreversible receptor modification by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): evidence for spare receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

Two sites in the third inner loop of the dopamine D2 receptor are involved in functional G protein-mediated coupling to adenylate cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900566-8

10.1016/S0024-3205(96)00566-8

7 January 2021

Identifiers

DOI

1 reference

2 September 2017

1 reference